5 курс / Пульмонология и фтизиатрия / Бронхиальная_астма_В_2_томах_Том_1_Чучалин_А_Г_1997
.pdfCoyle A.J., Urwin S.C., Page C.P. et al. The effect of the selective PAF antagonist BN 52021 on PAFand antigen-induced bronchial hyper-reactivity and eosinophil accumulation. Eur. J. Pharmacol. 1988, 148(1): 51-58.
Coyle A.J., Page C.P., Atkinson L. et al. The requirement for platelets in allergen-induced late asthmatic airway obstruction. Eosinophil infiltration and heightened airway responsiveness in allergic rabbits. Am. Rev. Respir. Dis. 1990,142 (3): 587-593.
Coyle A.J., Uchida D., Ackerman S.J. et al. Role of cationic proteins in the airway. Hyperresponsiveness due to airway inflammation. Am. J. Respir. Crit. Сате Med. 1994,150 (5 Pt 2): S63-S71.
Cuss F.M., Dixon C.M., Barnes P./Effects of inhaled platelet activating factor on pulmonary fiinctionand bronchial responsiveness in man.Lancet. 1986, 2: 189-192.
Cuss F.M., Barnes P.J. Airway smooth muscle and disease workshop: epithelial mediators. Am. Rev. Respir. Dis. 1987,136 (4 Pt 2): S32-S35.
Darius H., LeferD.J., Smith J.B., LeferAM. Role ofplatelet-activating factor acether in mediating guinea pig anaphylaxis. Science. 1986, 232: 58-60.
Darius H., Smith J.B., LeferAM. Inhibition ofthe platelet activating factor mediated component of guinea pig anaphylaxis by receptor antagonists. Int. Arch. Allergy Appl. Immunol. 1986, 80 (4): 369-375.
DelPrete G.F., De CarliM., D 'EliosМ.M. etal. Allergen exposure induces the activation ofallergenspecific Th2 cells in the airway mucosa ofpatients with allergic respiratory disorders. Eur. J. Immunol. 1993, 23 (7): 1445-1449.
DeMonchy J.G., Kauffman H.F., Venge P. et al. Bronchoalveolar eosinophilia during allergeninduced late asthmatic reactions. Am. Rev. Respir. Dis. 1985, 131 (3): 373-376.
Dewar A., Archer C.B., Paul W. et al. Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig. J. Pathol. 1984, 144 (1): 25-34.
Drazen J.M., Austen KF. Leukotrienes and airway responses. Am. Rev. Respir. Dis. 1987,136 (4): 985-998.
Dunnill M.S. The pathology of asthma, with special reference to changes in the bronchial mucosa. J. Clin. Pathol. 1960,13: 27-33.
Durham S.R., Carroll М., Walsh G.M., Kay A.B. Leukocyte activation in allergen-induced latephase asthmatic reaction. N. Engl. J. Med. 1984, 311 (22): 1398-1402.
Durham S.R., Dawes J., KayA.B. Platelets in asthma. Lancet. 1985, 2: 36.
Durham S.R., Loegering D.A., Gleich G.J., Kay A.B. Eosinophils, non-specific bronchial responsiveness and allergeninduced late-phase asthmatic reactions. J. Allergy. 1985,75 (1 Pt2, A173): 148.
Durham S.R., KayA.B. Eosinophils, bronchial hyperreactivity, and late-phase asthmatic reactions. Clin. Allergy. 1985,15 (5): 411-418.
Durham S., Graneek B., Hawkins R., Newman Taylor A. Increases in non-specific bronchial responsiveness precede the late asthmatic reaction induced by occupational agents. J. Allergy. 1986, 77(1 Pt2, A210): 173.
Durham S.R., Graneek B.J., Hawkins R., TaylorA.J. The temporal relationship between increases in airway responsiveness to histamine and late asthmatic responses induced by occupational agents. J. Allergy. 1987, 79 (2): 398-406.
Emre U., Roblin P.M., Gelling M. et al. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch. Pediatr. Adolesc. Med. 1994,148 (7): 727-732.
Engels F., Oosting R.S., Henricks P.A., Nijkamp F. P. The involvement of reactive hydroxyl radicals in Haemophilus influenzae-induced deterioration ofguinea pig lung beta-adrenergic receptor function. Agents Actions. 1985, 17 (3-4): 403-404.
Erger R.A., Casale T.B. Interleukin-8 is a potent mediator of eosinophil chemotaxis through endothelium and epithelium. Am. J. Physiol. 1995, 268 (1 Pt 1): LI 17-L122.
230
Evans T.W., Chung K.F., Rogers D.F., Barnes P.J. Effect of platelet-activating factor on airway vascular permeability: possible mechanisms. J. Appl. Physiol. 1987, 63 (2): 479-484.
Ferguson A. C., Vaughan R., Brown H., Curtis C. Evaluation ofserum eosinophilic cationic protein as a marker ofdisease activity in chronic asthma. J. Allergy. 1995, 95 (1 Pt 1): 23-28.
Filley W.V, Holley K.E., Kephart G.U., Gleich G.J. Identification by immunofluorescence of eosinophil granule m^jorbasic protein in lung tissues ofpatients with bronchial asthma. Lancet. 1982, 2:11-16.
Fink A., Weisman Z., Bentwich Z. The effect of leukotriene C4 (LTC4) and platelet-activating factor (PAF) on cilliary function - a useful in vitro model. Allergy Proc. 1988, 9 (4): A441.
Finney M.J., Karisson J.A., Persson C.G. Effects ofbronchoconstrictors and bronchodilators on a novel human small airway preparation. Br. J. Pharmacol. 1985, 85 (1): 29-36.
Flint K.C., Leung K.B.P., Hudspith B.N. et al. Bronchoalveolar mast cell in extrinsic asthma: a mechanism for the initiation ofantigen specific bronchoconstriction. Br. Med. J. 1985,291:923-926.
Folkerts G., Nijkamp F.P. Induction ofguinea pig respiratory airway hyperreactivity by Haemophilus influenzae: role of the histaminergic and cholinergic receptor systems. Agents Actions. 1985,17 (3- 4): 399-400.
Ford-Hutchinson A.W., Bray M.A., Doig M.V. et al. Leukotriene В a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 1980,286:264-265.
FrewA.J., Chan H., Lam S. etal. Bronchial inflammation in occupational asthma due to western red cedar. Am. J. Respir. Crit. Care Med. 1995,151 (2 Pt 1): 340-344.
Frigas E., Loegering D.A., Gleich G.J. Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. Lab. Invest. 1980,42 (1): 35-43.
Frigas E., Gleich G.L. The eosinophil and the pathophysiology of asthma. J. Allergy. 1986,77 (4): 527-537.
Frossard N., Rhoden K.J., Barnes P.J. Influence of epithelium on guinea pig airway responses to tachykinins: role ofendopeptidase and cyclooxygenase. J. Pharmacol. Exp. Ther. 1989,248 (1): 292298.
FryerA.D., Jacoby D.B. Effect of inflammatory cell mediators on М2 muscarinic receptors in the lungs. Life Sci. 1993, 52 (5-6): 529-536.
Fukuda T. The eosinophil and bronchial asthma (abstract). Nippon. Rinsho. 1993, 51: (3): 752758.
Fukuda Т., Nakajima H., Fukushima Y. et al. Detection of interleukin-5 messenger RNA and interleukin-5 protein in bronchial biopsies from asthma by nonradioactive in situ hybridization and immunohistochemistry. J. Allergy. 1994,94 (3 Pt 2): 584-593.
Fuller R. W., Morris P.K., RichmondR. et al. Immunoglobulin E-dependent stimulation ofhuman alveolar macrophages: significance oftype 1 hypersensitivity. Clin. Exp. Immunol. 1986,65 (2): 416426.
GavettS.H., Chen X., Finkelman F. etal. Depletion ofmurine CD4 T lymphocytes prevents antigeninduced airway hyperreactivity and pulmonaty eosinophilia. Am. J. Respir. Cell. Mol. Biol. 1994,10 (6): 587-593.
Gibson P.G., DolovichJ., Girgis-GabardoA. etal. The inflammatory response in asthma exacerbation: changes in circulating eosinophils, basophils and their progenitors. Clin. Exp. Allergy. 1990, 20 (6): 661-668.
Gil J.C., Cedillo R.L., Mayagoitia B.G., Paz M.D. Isolation of Mycoplasma pneumoniae from asthmatic patients. Ann. Allergy. 1993, 70 (1): 23-25.
Gilman A.G. Guanine nucleotide-binding regulatory proteins and dual control of adenylate cyclase. J. Clin. Invest. 1984, 73 (1): 1-4.
Gleich G.J., LoegeringD.A., Adolphson C.R. Eosinophils and bronchial inflammation. Chest. 1985, 87(1 Suppl.): 10S-13S.
231
Gleich G.J., Adolphson C.R., Leiferman K.M. The biology of the eosinophilic leukocyte. Annu. Rev. Med. 1993,44: 85-101.
Godfrey S. Airway inflammation, bronchial reactivity and asthma. Agents Actions. Suppl. 1993, 40 (Suppl.): 109-143.
Goldman D.W., Goetzl E.J. Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes. J. Immunol. 1982, 129 (4): 1600-1604.
Gourdon C., Pauli G. Responsabilite des infections virales dans l’asthme. Presse-Med. 1993, 22 (10): 480-486.
Grandordy B.M., Cuss F.M., Meldrum L. etal. Leukotrienes C4 and D4 induce contraction and formation of inositol phosphates in airways and lung parenchyma. Am. Rev. Respir. Dis. 1986, 133 (4): A239.
Grandordy B.M., Cuss F.M., Sampson A.S. et al. Phosphatidylinositol response to cholinergic agonists in airway smooth muscle: relationship to contraction and muscarinic receptor occupancy. J. Pharmacol. Exp. Ther. 1986, 238 (1): 273-279.
Grandordy В. М., Rhoden К., Barnes P.J. Effects ofprotein kinase С activation on adrenoceptors in airway smooth muscle. Am. Rev. Respir. Dis. 1987, 135 (4): A272.
Grandordy В.М., CussF.M., Barnes P.J. Breakdown ofphosphoinositides in airway smooth muscle: lack of influence of anti-asthmatic drugs. Life Sci. 1987,41 (13): 1621-1627.
Gross A., Ben-Sasson S.Z., Paul W.E. Anti-IL-4 diminishes in vivo priming for antigen-specific IL-4 production by T cells. J. Immunol. 1993, 150 (6): 2112-2120.
Haas H., Morris J.F., Samson S. et at. Bacterial flora of the respiratory tract in chronic bronchitis: comparison of transtracheal, fiberbronchoscopic, and oropharyngeal sampling methods. Am. Rev. Respir. Dis. 1977, 116 (1): 41-47.
Hahn D.L., Golubjatnikov R. Asthma and chlamydial infection: a case series. J. Fam. Pract. 1994, 38 (6): 589-595.
Hahn H.L., Purnama /., Lang М., Sannwald U. Effects of platelet activating factor on tracheal mucus secretion, on airway mechanics and on circulating blood cells in live ferrets. Eur. J. Respir. Dis. 1986,146 (Suppl.): 277-284.
Hahn H.L., Hartlapa J., Lang M. Effect of platelet activating factor on submucosal gland morphologycomparison to acetylcholine. Fed. Proc. 1986,45 (3, A3085): 686.
Hall W.J., Hall C.B., Speers D.M. Respiratory syncitial virus infection in adults: clinical, virologic, and serial pulmonary function studies. Ann. Int. Med. 1978, 88 (2): 203-205.
Halonen М., Palmer J.D., Me Manus L.M., Pincard R.N. Respiratory and circulatory alterations induced by acetyl glyceryl ether phosphorylcholine, a mediator of IgE anaphylaxis in the rabbit. Am. Rev. Respir. Dis. 1980, 122 (6): 915-924.
Halonen М., Palmer J.D., Lohman I.C. et al. Differential effects of platelet depletion on the physiologic alterations of IgE anaphylaxis and acetyl glyceryl ether phosphorylcholine infusion in the rabbit. Am. Rev. Respir. Dis. 1981, 124 (4): 416-421.
Hallsworth M.P., Soh C.P., Lane S.J. etal. Selective enhancement of GM-CSF, TNF-alpha, IL-1 beta and IL-8 production by monocytes and macrophages of asthmatic subiects. Eur. Respir. J. 1994, 7(6): 1096-1102.
Hamasaki K, Mojarad М., Saga T. etal. Platelet-activating factor raises airway and vascularpressures and induced edema in lungs perfused with platelet-free solution. Am. Rev. Respir. Dis. 1984, 129 (5): 742-746.
Hansel T.T., Walker C. The migration of eosinophils into the sputum of asthmatics: the role of adhesion molecules. Clin. Exp. Allergy. 1992, 22 (3): 345-356.
Hardy C.C., Robinson C., TattersfieldA.E., Holgate S. T. The bronchoconstrictior effect of inhaled prostaglandin D2 in normal and asthmatic men. N. Engl. J. Med. 1984, 311 (4): 209-213.
Hegele R.G., HayashiS., BramleyA.M., HoggJ.C. Persistence ofrespiratory syncytial virus genome and protein after acute bronchiolitis in guinea pigs. Chest. 1994, 105 (6): 1848-1854.
232
Henocq E., VargaftigВ. B. Accumulation ofeosinophils in response to intracutaneous PAF-acether and allergens in man. Lancet. 1986, 1:1378-1379.
Hirata F., Axelrod J. Phospholipid methylation and biological signal transmission. Science. 1980, 209:1082-1090.
HoggJ. C. Bronchial mucosal permeability and its relationship to airways hyperreactivity. J. Allergy. 1981,67 (6): 421-425.
HoggJ.C. The pathology of asthma. Clin. Chest Med. 1984, 5 (4): 567-571.
HoggJ.C., Pare P.D., Moreno R. The effect of submucosal edema on airway resistance. Am. Rev. Respir. Dis. 1987, 135 (6 Pt 2): S54-S56.
Holgate S. T. The human lung mast cell: morphology, biochemistry and role in allergic asthma. Adv. Med. 1983, 19: 287-306.
Holgate S. Т., KayA.B. Mast cells, mediators and asthma. Clin. Allergy. 1985,15 (3): 221-234. Holgate S.T., Djukanovic R., Wilson J. et al. Allergic inflammation and its pharmacological
modulation in asthma. Int. Arch. Allergy Appl. Immunol. 1991, 94 (1-4): 210-217.
Holgate S. T. The 1992 Cournand Lecture. Asthma: past, present and future. Eur. Respir. J. 1993, 6(10): 1507-1520.
Нот M.E., Brain E.A., GreggI. etal. Respiratory viral infection and wheezy bronchitis in childhood. Thorax. 1979, 34(1): 23-28.
HorwitzJ. Muscarinic receptor stimulation increases inositol-phospholipid metabolism and inhibits cyclic AMP accumulation in PC12 cells. J. Neurochem. 1989, 53 (1): 197-204.
HosseletJ.J. Role des molecules d’adhesion dans 1 ’inflammation bronchique et 1 ’hyperreactivite bronchique. Allerg. Immunol. Paris. 1994, 26 (8): 278-282.
Hua X., Lundberg J.M., Theodorsson-Norheim £., Brodin E. Comparison of cardiovascular and bronchoconstrictor effects ofsubstance P, substance К and othertachykinins. Naynon Schmiedebergs Arch. Pharmacol. 1984, 328 (2): 196-201.
HudgelD. W., Langston L.JR., SeinerJ.C., McIntosh K. Viral and bacterial infections in adults with chronic asthma. Am. Rev. Respir. Dis. 1979, 120 (2): 393-397.
Hunter J.A., Finkbeiner W.E., Nadel J.A. et al. Predominant generation of 15-lipoxygenase metabolites of arachidonic acid by epithelial cells from human trachea. Proc. Natl. Acad. Sci. USA. 1985,82(14): 4633-4637.
Hwang S.B., Lam M.H., Shen T. Y. Specific binding sites for platelet activating factor in human lung tissues. Biochem. Biophys. Res. Commun. 1985, 128 (2): 972-979.
Ihre E., Zetterstrom O. Increase in non-specific bronchial responsiveness after repeated inhalation of low doses of allergen. Clin. Exp. Allergy. 1993, 23 (4): 298-305.
Ishizaka K., Ishizaka T. The significance of immunoglobulin E in reaginic hypersensitivity. Ann. Allergy. 1970, 28: 189-202.
Ishizaka K., Ishizaka T. Mechanisms of reaginic hypersensitivity: a review. Clin. Allergy. 1971, 1: 9-24.
Ishizaka K., Ishizaka T. IgE and reaginic hypersensitivity. Ann. N.Y. Acad. Sci. 1971, 190: 443456.
Ishizaka K., Ishizaka T. Mechanism of reaginic hypersensitivity and IgE antibody response. Immunol. Rev. 1978, 41: 109-148.
Ishizaka Т., Sato C.S., Ishizaka K. Mechanisms ofpassive sensitization. 3. Number of IgE molecules and their receptor sites on human basophil granulocytes. J. Immunol. 1973, 111 (2): 500-511.
Ishizaka T. IgE and mechanisms of IgE-mediated hypersensitivity. Ann. Allergy. 1982, 48 (6): 313-319.
Jacoby D.B., ChoiA.M. Influenza virus induces expression ofantioxidant genes in human epithelial cells. Free Radic. Biol. Med. 1994, 16 (6): 821-824.
Joseph М., Auriault C., Capron A. et al. A new function for platelets: IgE-dependent killing of schistosomes. Nature. 1983, 303: 810-812.
233
Juniper E.F., Frith P.A., Hargreave F.E. Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax. 1981, 36 (8): 575-579.
KalinerM., ShelhamerJ.H., DaviesP.B. etal. Autonomic nervous system abnormalities and allergy. Ann. Intern. Med. 1982, 96 (3): 349-357.
Kameyoshi Y, SchroderJ.М., Christophers E., Yamamoto S. Identification ofthe cytokine RANTES released from platelets as an eosinophil chemotactic factor. Int. Arch. Allergy Appl. Immunol. 1994, 104(1): 49-51.
Kava T. Effect of respiratory infections on exacerbation ofasthma in adult patients. Allergy. 1986, 41 (8): 556-561.
Kirby J.G., Hargreave F.E., Gleich G.J., O’Byrrte P.M. Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am. Rev. Respir. Dis. 1987, 136 (2): 379-383.
Kita H., Ohnishi Т., Okubo Y. et al. Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J. Exp. Med. 1991, 174 (3): 745-748.
Kline J.N., Hunninghake G. W. T-lymphocyte dysregulation in asthma. Proc. Soc. Exp. Biol. Med. 1994, 207 (3): 243-253.
Kobayashi Т., Hashimoto S., Imai K. et al. Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and sE-selectin levels in bronchial asthma. Clin. Exp. Immunol. 1994, 96 (1): 110-115.
Kroegel C., Yukawa Т., Dent G. etal. Platelet-activating factor induces eosinophil peroxidase release from purified human eosinophils. Immunology. 1988, 64 (3): 559-562.
Kroegel C., VirchowJ.C.Jr., Luttmann W. etal. Pulmonary immune cells in health and disease: the eosinophil leucocyte. Eur. Respir. J. 1994, 7 (3): 519-543.
Kroegel C., Hafner D., Walker C. et al. Immunpathogenese des allergischen Asthma bronchiale. Nachweis aktivierter CD25-CD4-Lymphozyten und Freisetzung von Zytokinen im Bronchoalveolarraum nach segmentaler Allergenprovokation. Dtsch. Med. Wochenschr. 1995, 120 (1-2): 10-17.
Kuehl F.A.Jr., De Haven R.N., Pong S.S. Lung tissue receptors for sulfidopeptide leukotrienes. J. Allergy. 1984, 74 (3 Pt 2): 378-381.
Kuna P., Alam R., Rozniecki J., Kuzminska B. Effect of autogenic bacterial antigens on the production ofhistamine releasing factorby mononuclear cells from intrinsic asthmatic patients. Allergy. 1988,43 (7): 511-518.
Kung Т. Т., Jones H., Adams G.K. et al. Characterization of a murine model of allergic pulmonary inflammation. Int. Arch. Allergy Appl. Immunol. 1994,105 (1): 83-90.
Lagente V, Touvay C., Randon J. etal. Interference ofthe PAF-acetherantagonist BN 52021 with passive anaphylaxis in the guineapig. Prostaglandins. 1987, 33 (2): 265-274.
Lai C.K., Chan C.H., Leung J.C. etal. Serum concentration of soluble interleukin 2 receptors in asthma. Correlation with disease activity. Chest. 1993,103 (3): 782-786.
Laitinen A., Laitinen L.A. Airway morphology: epithelium/basement membrane. Am. J. Respir. Crit. Care Med. 1994,150 (5 Pt 2): S14-S17.
Laitinen L.A., Laitinen A., Widdicombe J. Effects of inflammatory and other mediators on airway vascular beds. Am. Rev. Respir. Dis. 1987, 135 (6 Pt 2): S67-S70.
Laitinen L.A., Laitinen A., Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am. Rev. Respir. Dis. 1993,147 (3): 697-704.
Lam S., LeRiche J. C., KijekK., Phillips D. Effect ofbronchial lavage volume on cellular and protein recovery. Chest. 1985, 88 (6): 856-859.
Lam S., LeRiche J., Phillips D., Chan-YeungM. Cellular and protein changes in bronchial lavage fluid after late asthmatic reaction in patients with red cedar asthma. J. Allergy. 1987, 80 (1): 44-50.
Lam S., Chan H., LeRiche J.C. et al. Release of leukotrienes in patients with bronchial asthma. J. Allergy. 1988,81 (4): 711-717.
234
LazaarA.L., Albelda S.М., Pilewski J.M. et al. T lymphocytes adhere to airway smooth muscle cells via integrins and CD44 and induce smooth muscle cell DNA synthesis. J. Exp. Med. 1994,180 (3): 807-816.
Lee Т., Lenihan D.J., Malone B. etal. Increased biosynthesis ofplatelet-activating factor in activated human eosinophils. J. Biol. Chem. 1984, 259 (9): 5526-5530.
L eff A.R., White S.R., Munoz N.M. et al. Parasympathetic involvement in PAF-induced contraction in canine trachealis in vivo. J. Appl. Physiol. 1987, 62 (2): 599-605.
Lellouch-Tubiana A., LefortJ., PflsterA.E., VargaftingB.B. Interactions between granulocytes and plateletswith the guinea-pig lung in passive anaphylactic shock. Correlationswith PAF-acetherinduced lesion. Int. Arch. Allergy Appl. Immunol. 1987, 83 (2): 198-205.
Lellouch-Tubiana A., LefortJ., Pirotzky E. etal. Ultrastructural evidence for extravascular platelet recruitment in the lung upon intravenous injection of platelet-activating factor (PAF-acether) to guinea-pigs. Br. J. Exp. Pathol. 1985, 66 (3): 345-355.
Lewis R.A., Soter N.A., Diamond P. T. et al. Prostaglandin D2 generation after activation ofrat and human mast cells with anti-IgE. J. Immunol. 1982,129 (4): 1627-1631.
Little J. W., Hall W.J., Douglas R.G. etal. Airway hyperreactivity and peripheral airway dysfunction in influenza A infection. Am. Rev. Respir. Dis. 1978, 118 (2): 295-303.
Lopez A.F., Sanderson C.J., Gamble J.R. et al. Recombinant human interleukin 5 is a selective activation of human eosinophil function. J. Exp. Med. 1988,167 (1): 219-224.
Lotner G.Z., Lynch J.M., Benz S.J., Henson P.M. Human neutrophil-derived platelet activating factor. J. Immunol. 1980, 124 (2): 676-684.
LundbergJ.M., Martling C.R., SariaA. Substance P and capsaicin-induced contraction of human bronchi. Acta Physiol. Scand. 1983,119 (1): 49-53.
LundbergJ.M., SariaA., Brodin E. et al. A substance P antagonist inhibits vagally induced increase in vascularpermeability and bronchial smooth muscle contraction in the guinea pig. Proc. Natl. Acad.
Sci. USA. 1983, 80 (4): 1120-1124.
LundbergJ.M., Hokfelt Т., Martling C.R. etal. Substance P-immunoreactive sensory nerves in the lower respiratory tract of varions mammals including man. Cell Tissue Rev. 1984, 235 (2): 251-261.
Lundberg J.M., Franco-Cereceda A., Hua X. et al. Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and ,
bronchoconstrictor effects of capsaicin. Eur. J. Pharmacol. 1985,108 (3): 315-319. |
|
Macek V., Sorli J., Kopriva S., Marin J. Persistent adenoviral infection and chronic airway |
|
obstruction in children. Am. J. Respir. Crit. Care Med. 1994,150 (1): 7-10. |
: |
MacGlashanD.WJr., SchleimerR.P, Peters S.P. etal. Generation ofleukotrienes by purified human |
|
lung mast cells. J. Clin. Invest. 1982, 70 (4): 747-751. |
|
Majno G., Shea S.M., LeventhalM. Endothelial contraction induced by histamine-type mediators. |
|
An electron microscopic study. J. Cell Biol. 1969, 42: 647-672. |
|
ManettiR., Barak V., Piccinni M.P. et al. Interleukin 1 favours the in vitro development oftype 2 T |
|
helper (Th2) human T-cell clones. Res. Immunol. 1994,145 (2): 93-100. |
|
Mardini I.A., Higgins N.C., Zhou S. et al. Functional behavior of the beta-adrenergic receptor- |
|
adenylyl cyclase system in rabbit airway epithelium. Am. J. Respir. Cell Mol. Biol. 1994,11 (3): 287- |
|
295. |
|
Marone G., Poto S., Petracca R. etal. Activation of human basophils by staphylococcal protein A. |
|
1. The role of cyclic AMP, arachidonic acid metabolites, microtubules and microfilaments. Clin. |
|
Exp. Immunol. 1982, 50 (3): 661-668. |
|
Marone G., Columbo М., Triggiani M. et al. Forskolin inhibits the release ofhistamine from human |
|
basophils and mast cells. Agents Actions. 1986,18 (1-2): 96-99. |
|
Martin R.R., White A. The in vitro release of leukocyte histamine by staphylococcal antigens. J. |
|
Immunol. 1969, 102: 437-441. |
|
235
Mazingue С., Carriere V, DessaintJ.P. etal. Regulation of IgE synthesis by macrophages expressing FcE-receptois: role of interleukin 1. Clin. Exp. Immunol. 1987, 67 (3): 587-593.
Meggs W.J. RADS and RUDS - the toxic induction ofasthma and rhinitis. J. Toxicol. Clin. Toxicol. 1994, 32 (5): 487-501.
MelbyeH., KongerudJ., VorlandL. Reversible airflow limitation in adultswith respiratory infection. Eur. Respir. J. 1994, 7 (7): 1239-1245.
Metzger W.J., Sjoerdsma K., Richerson H.B. etal. Platelets in bronchoalveolarlavage from asthmatic patients and allergic rabbits with allergen-induced late-phase responses. Agents Actions. 1987, 21 (Suppl.): 151-159.
Metzger W.J., Zavala D., Richerson H.B. etal. Local alleigen challenge and bronchoalveolar lavage ofallergic asthmatic lungs. Description ofthe model and local airway inflammation. Am. Rev. Respir. Dis. 1987,135 (2): 433-440.
Meurs H., Kauffman H.F., Koeter G.H. et al. Regulation of the beta-receptor-adenylate cyclase system in lymphocytes of allergic patients with asthma: possible role for protein kinase С in alleigeninduced nonspecific refractoriness of adenylate cyclase. J. Allergy. 1987,80 (3 Pt 1): 326-339.
Minor T.E., Dick E. C., BakerJ. W. et al. Rhinovirus and influenza type A infections as precipitants of asthma. Am. Rev. Respir. Dis. 1976,113 (2): 149-153.
Misawa M., Chiba Y. Repeated antigenic challenge-induced airwayhyperresponsiveness and airway inflammation in actively sensitized rats. Jpn. J. Pharmacol 1993, 61 (1): 41-50.
Montefort S., Lai C.K., Kapahi P. et al. Circulating adhesion molecules in asthma. Am. J. Respir. Crit. Care Med. 1994,149 (5): 1149-1152.
Montefort S., Gratziou C., Goulding D. et al. Bronchial biopsy evidence for leukocyte infiltration and upregulation ofleukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J. Clin. Invest. 1994, 93 (4): 1411-1421.
Morley Sanjar S., Page C.P. The platelet in asthma. Lancet. 1984, 2:1142-1144.
Morley J., Page C.P., Sanjar S. Pulmonary responses to platelet-activating factor. Prog. Respir. Res. 1985,19:117-123.
Morley J. Platelet activating factor and asthma. Agents Actions. 1986,19(1-2): 100-108. Morley J., Smith D. Lung inflammation, its significance for asthma therapy. Agents Actions. 1989,
26 (1-2): 31-39.
Morse S.I. Influence ofmicrobial products on allergic reaction. In Allergy: Principles and practice. Eds. E. Middleton, E.E. Reed, E.F. Ellis, C.V. Mosby. St. Louis, Missoiri. 1978:187-199.
Muller K.M., Jaunin F., Masouye I. et al. Th2 cells mediate IL-4-dependent local tissue inflammation. J. Immunol. 1993,150 (12): 5576-5584.
Murlas C.G., Roum J.H. Sequence of pathologic changes in the airway mucosa of guinea pigs during ozone-induced bronchial hyperreactivity. Am. Rev. Respir. Dis. 1985,131 (3): 314-320.
Murphy S., Kelly H. W. Asthma, inflammation, and airway hyperresponsiveness in children. Curr. Opin. Pediatr. 1993, 5 (3): 255-265.
Myou S., Fujimura М., Nishi K. et al. Inhibitory effect of a selective thromboxane synthetase inhibitor, OKY-046, on acetaldehyde-inducedbronchoconstriction in asthmatic patients. Chest. 1994, 106(5): 1414-1418.
Naclerio R.M., ProudD., TogiasA.G. etal. Inflammatory mediators in late antigen-induced rhinitis.
N.Engl. J. Med. 1985, 313 (2): 65-70.
Nakamura Т., Morita Y., Kuriyama M. et al. Platelet-activating factor in late asthmatic response.
Int. Arch. Allergy Appl. Immunol. 1987, 82 (1): 57-61.
Nambi P., Peters J.R., Sibley D.R., Lefkowitz RJ. Desensitization of the turkey erythrocyte betaadrenergic receptor in a cell-free system. Evidence that multiple protein kinases can phosphorylate and desensitize the receptor. J. Biol. Chem. 1985, 260 (4): 2165-2171.
Niimi A., Yamada K., Amitani R. et al. Airway inflammatory cell dynamics during late asthmatic reactions induced by toluene diisocyanate in guinea pigs. 1. Bronchoalveolar lavage study (abstract). Arerugi. 1993,42 (10): 1576-1584.
236
Nijkamp F.P., HenricksPA. Receptors in airwaydisease. Beta-adrenoceptors in lung inflammation. Am. Rev. Respir. Dis. 1990, 141 (3 Pt 2): S145-S150.
Nishizuka Y. The role ofprotein kinase С in cell surface signal transduction and tumor promotion. Nature. 1984, 308: 693-698.
Norn S., Stahl Skov P., Jensen C. et al. Bacteria-induced histamine release. Examination of the bacterial cell wall components peptidoglycan, teichoic acid and protein A. Agents Actions. 1985,16 (3-4): 273-276.
Norn S., Stahl Skov P., Jensen C. et al. Histamine release induced by bacteria. A new mechanism in asthma? Agents Actions. 1987, 20 (1-2): 29-34.
O'Flaherty J. Т., Surles J.R., Redman J. etal. Binding and metabolism ofplatelet-activating factor by human neutrophils. J. Clin. Invest. 1986, 78 (2): 381-388.
O’Flaherty J.T., Nishihira J. Arachidonate metabolites, platelet-activating factor, and the mobilization of protein kinase С in human polymorphonuclear neutrophils. J. Immunol. 1987, 138 (6): 1889-1895.
O'Flaherty J. T. Regulation of the metabolism and binding of platelet-activating factor. ISI atlas of science. Pharmacology. 1988,2 (4): 314-318.
Ohkawara Y, Yamauchi K., Maruyama N. etal. In situ expression of the cell adhesion molecules in bronchial tissues from asthmatics with air flow limitation: in vivo evidence of VCAM-l-VLA-4 interaction in selective eosinophil infiltration. Am. J. Respir. Cell Mol. Biol. 1995, 12 (1): 4-12.
Page C.P., Paul W., MorleyJ. Platelet and bronchospasm. Int. Arch. Allergy Appl. Immunol. 1984, 74 (4): 347-350.
Page C.P., Guerreiro D., Sanjar S., Morley J. Platelet activating factor (Paf-acether) may account for late-onset reactions to allergen inhalation. Agents Actions. 1985,16 (1-2): 30-32.
Page C.P., Tomiak R.H., Sanjar S., Morley J. Suppression of Paf-acether responses: an anti inflammatory effect of anti-asthma drugs. Agents Actions. 1985,16 (1-2): 33-35.
PalmerJ.B., Cuss F.M., Barnes P.J. Sensory neuropeptides and human airway function. Am. Rev. Respir. Dis. 1986, 133 (4): A239.
PalmerJ.B., Bames P.J. Neuropeptides and airway smooth muscle function. Am. Rev. Respir. Dis. 1987, 136 (4 Pt 2): S50-S54.
Pin I., Godard P. Mecanismes de Phyperreactivite bronchique: role de l’inflammation des voies aeriennes et de l’atopie. Rev. Mai. Respir. 1994, 11 (2): 111-122.
PiperP.J. Pharmacology and biochemistry ofthe leukotrienes. Eur. J. Respir. Dis. 1982,122(Suppl): 54-61.
Postma D.S., Oosterhoff Y, van-Aalderen W.M. et al. inflammation in nocturnal asthma. Am. J. Respir. Crit. Care Med. 1994,150 (5 Pt 2): S83-S86.
Prado G.N., Thomas K.M., Suzuki H. etal. Molecular characterization ofa novel rabbit interleukin- 8 receptor isotype. J. Biol. Chem. 1994, 269 (17): 12391-12394.
Raaijmakers J.A., BenekerC., van GeffenE.C. etal. Inflammatory mediators and beta-adrenoceptor function. Agents Actions. 1989, 26 (1-2): 45-47.
Radeau Т., Chavis C., Damon M. et al. Enhanced arachidonic acid metabolism and numan neutrophil migration in asthma. Prostaglandins Leukot. Essent. Fatty Acids. 1990, 41 (2): 131-138.
Raible D. G., Lenahan T., Fayvilevich Y. et al. Pharmacologic characterization ofa novel histamine receptor on human eosinophils. Am. J. Respir. Crit. Care Med. 1994,149(6): 1506-1511.
Reed C.E. The importance ofeosinophils in the immunology of asthma and allergic disease. Ann. Allergy. 1994, 72 (4): 376-380.
RiiseG.C., LarssonS., LofdahlC.G.,AnderssonB.A. Circulating cell adhesion molecules in bronchial lavage and serum in COPD patients with chronic bronchitis. Eur. Respir. J. 1994, 7 (9): 1673-1677.
Roberts N.M., Page C.P., ChungK.F., Bames P.J. Effect ofaPAF antagonists, BN52063, on antigeninduced, acute, and late-onset cutaneous responses in atopic subjects. J. Allergy. 1988, 82 (2): 236241.
237
Robinson D.S., Hamid Q., YingS. etal. Predominant TH2-like bronchoalveolarT-lymphocyte population in atopic asthma. N. Engl. J. Med. 1992, 326 (5): 298-304.
Robinson D.S., BentleyA.M., HartnellA. etal. Activated memory T helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: relation to asthma symptoms, lung function, and bronchial responsiveness. Thorax. 1993,48 (1): 26-32.
RomagniniS. Human TH1 and TH2 subsets: doubt no more. Immunol. Today. 1991,12(8): 256257.
Rossi O.V., Kinnula V.L., Tuokko H., Huhti E. Respiratory viral and Mycoplasma infections in patients hospitalized for acute asthma. Monaldi. Arch. Chest Dis. 1994, 49 (2): 107-111.
Rubin A-H.E., Smith L.J., Patterson R. The bronchoconstrictor properties of platelet-activating
factor in humans. Am. Rev. Respir. Dis. 1987,136 (5): 1145-1151. |
1 |
Saijo М., Ishii Т., Kokubo M. et al. Respiratory syncytial virus infection in lower respiratory tract and asthma attack in hospitalized children in North Hokkaido, Japan. Acta Paediatr. Jpn. 1993, 35 (3): 233-237.
Santing R.E., Olymulder C.G., Zaagsma J. et al. Relationships among allergen-induced early and late phase airway obstructions, bronchial hyperreactivity, and inflammation in conscious, unrestrained guinea pigs. J. Allergy. 1994, 93 (6): 1021-1030.
Schellenberg R.R., Walker B. Platelet-dependent contraction of human bronchus by plateletactivating factor. J. Allergy. 1983, 71 (1 Pt 2, A227): 145.
Schenkelaars E.J., Bonta I.L. Beta2-adrenoceptor agonists reverse the leukotriene C4-induced release response of macrophages. Eur. J. Pharmacol. 1985,107 (1): 65-70.
Schleimer R.P. Effects ofglucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma. Am. Rev. Respir. Dis. 1990, 141 (2 Pt 2): S59-S69.
Schreurs A.J.M., Terpstra G.K., Raaijmakers J.A.M., Nijkamp F.P. The effects of Haemophillus influenzae vaccination on anaphylactic mediator release and isoprenalihe-induced inhibition of mediator release. Eur. J. Pharmacol. 1980, 62 (4): 261-268.
SchreursA.J., Nijkamp F.P. Haemophilus influenzae induced loss oflungbeta-adrenoceptor binding sites and modulation by changes in peripheral catecholaminergic input. Eur. J. Pharmacol. 1982, 77 (2-3): 95-102.
Schreurs A.J.M., VerhoefJ., Nijkamp F.P. Bacterial cell wall components decrease the number of guinea-pig lungbeta-adrenoceptors. Eur. J. Pharmacol. 1983, 87 (1): 127-432.
Schulman E.S., Liu M.C., ProudD. etal. Human lung macrophages induce histamine release from basophils and mast cells. Am. Rev. Respir. Dis. 1985,131 (2): 230-235.
Sedgwick J.B., Calhoun W.J., VrtisR.F. etal. Comparison ofairway and blood eosinophil function after in vivo antigen challenge. J. Immunol. 1992,149(11): 3710-3718.
SeltzerJ., BigbyB.G., StulbargM.S. etal. ОЗ-induced change in bronchial reactivityto methacholine and airway inflammation in humans. J. Appl. Physiol. 1986, 60 (4): 1321-1326.
Shiota Y., Sato Т., Ono T. Serum levelsofsoluble CD25 (soluble interleukin 2 receptor) in asthmatic patients (abstract). Arerugi. 1993,42 (8): 914-919.
Sibley D.R., NambiP, PetersJ.R., Le/kowitzR.J. Phorbol diesterspromote beta-adrenergic receptor phosphorylation and adenylate cyclase desensitization in duck erythrocytes. Biochem. Biophys. Res. Commun. 1984, 121 (3): 973-979.
Sibley D.R., Lefkowitz RJ. Biochemical mechanisms of beta-adrenergic receptor regulation. ISI atlas of science. Pharmacology. 1988, 2: 66-70.
Sigurs N., Bjamason R., Sigurbergsson F. Eosinophil cationic protein in nasal secretion and in serum and myeloperoxidase in serum in respiratory syncytial virus bronchiolitis: relation to asthma and atopy. Acta Paediatr. 1994, 83 (11): 1151-1155.
Sim T.C., Hilsmeier K.A., Reece L.M. et al. Interleukin-1 receptor antagonist protein inhibits the synthesis of IgE and proinflammatory cytokines by allergen-stimulated mononuclear cells. Am. J. Respir. Cell Mol. Biol. 1994,11 (4): 473-479.
238
Simon H. U., Grotzer М., Nikolaizik W.H. et al. High altitude climate therapy reduces peripheral blood T lymphocyte activation, eosinophilia, and bronchial obstruction in children with house-dust mite allergic asthma. Pediatr. Pulmonol. 1994,17 (5): 304-311.
Simon H. V , Tsao P. W., Siminovitch K.A. et al. Functional platelet-activating factor receptors are expressed by monocytes and granulocytes but not by resting or activated T and В lymphocytes from normal individuals or patients with asthma. J. Immunol. 1994,153 (1): 364-377.
Sin B., MisirligilZ., Demirel Y.S. et al. Increased chemotactic responses of neutrophils in intrinsic and mixed asthmatic patients. Allergol. Immunopathol. Madr. 1994, 22 (5): 204-208.
Snella М. C., Rylander/{.Lung cell reactions after inhalation ofbacterial lipopolysaccharides. Eur. J. Respir. Dis. 1982,63 (6): 550-557.
SnyderF. Chemical and biochemical aspects ofplatelet activating factor: a novel class ofacetylated ether-linked choline-phospholipids. Med. Res. Rev. 1985, 5 (1): 107-140.
SorknessR., Clough J.J., Castleman W.L., Lemanske R.F.Jr. Virus-induced airway obstruction and parasympathetic hyperresponsiveness in adult rats. Am. J. Respir. Crit. Care Med. 1994,150 (1): 2834.
Spence D.P., Johnston S.L., Calverley P.M. et al. The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment ofasthma. Am. J. Respir. Crit. Care Med. 1994,149 (5): 1142-1148.
Stevens W.H., Lane C.G., Woolley M.J. et al. Effect of FLAP antagonist MK-0591 on leukotriene production and ozone-induced airway responses in dogs. J. Appl. Physiol. 1994, 76 (4): 1583-1588.
Stimler N.P., О’Flaherty J. T. Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response ofpulmonary tissues. Am. J. Pathol. 1983,113 (1): 7584.
SunJ., Elwood W., HaczkuA. etal. Contribution ofintercellular-adhesion molecule-1 in allergeninduced airway hyperresponsiveness and inflammation in sensitised brown Norway rats. Int. Arch. Allergy Appl. Immunol. 1994,104(3): 291-295.
Symon F.A., Walsh G.M., Watson S.R. et al. Eosinophil adhesion to nasal polyp endothelium is P- selectin - dependent. J. Exp. Med. 1994,180 (1): 371-376.
TakahashiN., LiuM.C., ProudD. etal. Soluble intercellular adhesion molecule in bronchoalveolar lavage fluid ofallergic subjects following segmental antigen challenge. Am. J. Respir. Crit. Care Med. 1994,150 (3): 704-709.
Tamura N., Agrawal D.K., Suliaman F.A., Townlay R. G. Effects ofplatelet activating factor on the chemotaxis of normodense eosinophils from normal subiects. Biochem. Biophys. Res. Commun. 1987, 142 (3): 638-644.
Tamura N., Agrawal D.K., Townley R.G. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on epsinophil activation. J. Immunol. 1988, 141 (12): 4291-4297.
Tanaka D. Т., Grunstein M.M. Mechanisms of substance P-induced contraction of rabbit airway smooth muscle. J. Appl. Physiol. 1984, 57 (5): 1551-1557.
Tanizpki Y, Kitani H., Okazaki M. etal. Airway inflammation and bronchial hyperresponsiveness in patients with asthma. Comparison between atopic and nonatopic asthma. Arerugi. 1993, 42 (1): 26-33.
Tanizaki Y., Kitahi H., Mifune T. etal. Effects ofglucocorticoids on humoral and cellular immunity and on airway inflammation in patients with steroid-dependent intractable asrhma. J. Asthma. 1993, 30 (6); 485-492.
Tashkin D.P., Simmons M.S., Chang P. et al. Effects of smoked substance abuse on nonspecific airway hyperresponsiveness. Am. Rev. Respir. Dis. 1993, 147 (1): 97-103.
Tomassini М., Magrini L., De Petrillo G. et al. Serum levels of eosinophil cationic protein and allergy exposure. J. Allergy. 1993, 91 (1 Pt 2): 180.
239